ICS 2015 Scientific Podium Short Oral Session S14 - Male Lower Urinary Tract Dysfunction

Male Lower Urinary Tract Dysfunction

Speakers
	Scientific Podium Short Oral Session S14
	Wednesday 7th October 2015
	16:00 - 17:30
	210AE
	Lunch provided
E Edwin Paterson Arnold ICS Chair G Gregory G Bailly ICS Chair
Learning Objectives
To examine novel research findings in the field of Male Lower Urinary Tract Dysfunction. To discuss methodological challenges for conducting research in the field of Male Lower Urinary Tract Dysfunction. To discern the internal and external generalizability of these research results in order to implement changes in research methods or clinical practice within the participant's own setting.

Session Schedule

16:00

#201 PREDICTION OF URINARY INCONTINENCE AFTER ROBOT-ASSISTED RADICAL PROSTATECTOMY

Presenter: Masashi Honda

Honda M¹, Kawamoto B¹, Tsounapi P¹, Hikita K¹, Muraoka K¹, Shimizu S², Satio M², Sejima T¹, Takenaka A¹
1. Department of Urology, Tottori University Faculty of Medicine, 2. Department of Pharmacology, Kochi Medical School
Incontinence, Male, Surgery

16:07

#202 One year follow-up of sexual function and penile rehabilitation strategies in the first year after open and robot radical prostatectomy.

Presenter: Inge Geraerts

Geraerts I¹, Van Poppel H², Van Kampen M¹, Van Kampen M¹
1. KU Leuven- Department of Rehabilitation Sciences, 2. UZ Leuven- Urology
Male, Sexual Dysfunction , Prospective Study

16:15

#203 Effects of time, volume, and location on artificial urinary sphincter pressure regulating balloon pressures

Presenter: Stephen Marshall

Marshall S¹, Geminiani J¹, Ho T¹, Vetter J¹, Brandes S¹
1. Washington University in St. Louis
Surgery, Incontinence, Male

16:22

#204 Proof of principle for a temporary patient-operated intraurethral valve device in management of incontinence after radical prostatectomy

Presenter: Marcus Drake

Drake M¹, Morris N¹, Gammie A¹, Devery D², Timothy M²
1. Bristol Urological Institute, 2. Vysera BioMedical
Clinical Trial, Incontinence, Male, New Devices

16:30

#205 EFFICACY AND SAFETY OF A NEW ADJUSTABLE ARTIFICIAL URINARY SPHINCTER (AROYO™) FOR THE TREATMENT OF MALE STRESS URINARY INCONTINENCE: RELIEF I STUDY WITH 12 MONTHS FOLLOW-UP

Presenter: Roman Zachoval

Zachoval R¹, Krhut J², Stejskal J³, Mika D², Oelke M⁴
1. Department of UrologyThomayer Hospital and 1st and 3rd Medical Faculty, Charles University, Prague, Czech Republic, 2. Department of Urology, Faculty Hospital, Ostrava, Czech Republic, 3. Department of Urology, Thomayer Hospital, Prague, Czech Republic, 4. Department of Urology, Hannover Medical School, Germany
Stress Urinary Incontinence, Surgery, Clinical Trial, New Devices, Male

16:37

#206 The ATOMS device for male stress urinary incontinence: 5 year results of a prospective-multicenter study

Presenter: Alexander Friedl

Friedl A¹, Mühlstädt S², Rom M³, Kivaranovic D⁴, Mohammed N², Fornara P², Brössner C¹
1. Department of Urology, Hospital Göttlicher Heiland, Vienna, 2. Department of Urology and Kidney Transplantation, Martin Luther-Medical School, Halle, Germany, 3. Department of Urology, Vienna General Hospital, Medical University of Vienna, Vienna, Austria, 4. Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University Vienna, Vienna
Male, Stress Urinary Incontinence, Surgery, Prospective Study

16:45

#207 Management of male lower urinary tract symptoms: ability to correctly identify and consequences of incorrect consumer decision

Presenter: Franklin C Lowe

Roehrborn C G¹, Lowe F C², Gittelman M³, Verbeek A E⁴, Wruck J M⁴
1. The University of Texas Southwestern, 2. Mount Sinai St Luke's/Roosevelt, 3. South Florida Medical Research, 4. Boehringer Ingelheim Pharmaceuticals, Inc.
Benign Prostatic Hyperplasia (BPH), Male, Quality of Life (QoL), Questionnaire

16:52

#208 Morphological and functional evaluation of prostatic urethra using sonourethrography with retrograde jelly injection

Presenter: Tomonori Minagawa

Minagawa T¹, Goto M¹, Domen T¹, Yokoyama H¹, Ishikawa M¹, Hiragata S¹, Nagai T¹, Nakazawa M¹, Ogawa T¹, Ishizuka O¹
1. Shinshu University
Benign Prostatic Hyperplasia (BPH), Male, Imaging, Voiding Dysfunction , Anatomy

17:00

#209 A prospective, six-year followup of silodosin monotherapy for the treatment of LUTS/BPH: what are the factors for continuation or withdrawal?

Presenter: Tomonori Yamanishi

Yamanishi T¹, Kaga K¹, Uchiyama T¹, Shibata C¹
1. Dokkyo Medical University, Continence Center
Benign Prostatic Hyperplasia (BPH), Bladder Outlet Obstruction , Male, Voiding Dysfunction , Conservative Treatment

17:07

#210 Efficacy of Holmium Laser Enucleation of the Prostate (HoLEP) in men with bladder outlet obstruction (BOO) and non-neurogenic bladder dysfunction: results of prospective trial.

Presenter: Jong Hyun Pyun

Pyun J H¹, Kang S G¹, Kang S H¹, Chun J¹, Kim J J¹, Lee J G¹
1. Department of Urology, Korea University Hospital
Benign Prostatic Hyperplasia (BPH), Detrusor Hypocontractility, Detrusor Overactivity, Bladder Outlet Obstruction

17:15

#211 Can feeling of incomplete bladder emptying reflect significant postvoid residual urine? Can we trust the patients?

Presenter: Zafer Aybek

Ozlulerden Y¹, Toktas C², Zumrutbas A E², Gulten M C², Baser A², Yapici O³, Aybek Z²
1. Aydin Ataturk State Hospital, Urology Clinic, 2. Pamukkale University School of Medicine, Department of Urology, 3. Denizli Acipayam State Hospital, Urology Clinic
Benign Prostatic Hyperplasia (BPH), Male, Voiding Dysfunction , Terminology

17:22

#212 Differential Impact of IPSS Storage and Voiding Symptom Sub-Scores in Patients Taking Tadalafil 5mg Once-Daily for LUTS Associated with BPH

Presenter: Craig Donatucci

Peterson A¹, Oelke M², McVary K³, Baygani S⁴, Henneges C⁵, Clouth J⁵, Wong D⁴, Donatucci C⁴
1. Department of Surgery and Urology, Duke University, Durham, North Carolina, USA, 2. Department of Urology, Hannover Medical School, Hannover, Germany, 3. Department of Urology, Southern Illinois University, Springfield, Illinois, USA, 4. Lilly Research Laboratories, Eli Lilly and Co., Indianapolis, Indiana, USA, 5. Lilly Deutschland GmbH, Bad Homburg, Germany
Benign Prostatic Hyperplasia (BPH), Quality of Life (QoL), Male, Mathematical or statistical modelling

International Continence Society

Male Lower Urinary Tract Dysfunction

Session Schedule

Comments

Chat